Early research indicated that short hairpin RNA (shRNA) mediated silencing of METTL3 in several glioma cell lines, both in vitro as well as in in vivo orthotopic models, resulted in enhanced GBM growth [19]. Here, METTL3 is linked to central nervous system cancer.